2010
DOI: 10.1016/j.jss.2009.05.045
|View full text |Cite
|
Sign up to set email alerts
|

Platonin Improves Survival of Skin Allografts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 41 publications
(47 reference statements)
0
2
0
Order By: Relevance
“…The 6-MITC induces G2/M phase arrest in cancer cells and is capable of blocking the KRAS/BRAF and PI3K/AKT signaling pathways [ 11 , 12 ]. Because the effect of these compounds on alloantigen recognition and T-cell activation are unknown, we established an experimental skin allograft model as a drug screen for immunosuppressants following transplantation [ 14 , 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…The 6-MITC induces G2/M phase arrest in cancer cells and is capable of blocking the KRAS/BRAF and PI3K/AKT signaling pathways [ 11 , 12 ]. Because the effect of these compounds on alloantigen recognition and T-cell activation are unknown, we established an experimental skin allograft model as a drug screen for immunosuppressants following transplantation [ 14 , 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…[3] DCs can be induced to di erentiate into a less mature stage or to acquire a tolerogenic phenotype. [4][5][6] is induced di erentiation suggests that modulation of DC development could have therapeutic potential in the treatment or prevention of diseases involving unwanted immune response, such as rejection of transplanted gra s. [7] Bisphosphonates have been widely used for treatment of excessive bone loss arising from increased number and activity of osteoclasts, such as that seen in osteoporosis from the aging process and bone metastasis from cancers. [8][9] Among various kinds of bisphosphonates, the nitrogen-containing bisphosphonates have been shown to inhibit farnesyl diphosphate synthase [10] and squalene synthase [11] of the mevalonate pathway, which interferes with protein prenylation of small GTPase to induce osteoclast apoptosis.…”
mentioning
confidence: 99%